SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-015162
Filing Date
2024-11-12
Accepted
2024-11-12 07:39:21
Documents
84
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zbio-20240930x10q.htm   iXBRL 10-Q 4721072
2 EX-31.1 zbio-20240930xex31d1.htm EX-31.1 15686
3 EX-31.2 zbio-20240930xex31d2.htm EX-31.2 15284
4 EX-32.1 zbio-20240930xex32d1.htm EX-32.1 8284
5 EX-32.2 zbio-20240930xex32d2.htm EX-32.2 7751
6 GRAPHIC zbio-20240930x10q004.jpg GRAPHIC 6769
  Complete submission text file 0001558370-24-015162.txt   10933741

Data Files

Seq Description Document Type Size
7 EX-101.SCH zbio-20240930.xsd EX-101.SCH 55569
8 EX-101.CAL zbio-20240930_cal.xml EX-101.CAL 49084
9 EX-101.DEF zbio-20240930_def.xml EX-101.DEF 222133
10 EX-101.LAB zbio-20240930_lab.xml EX-101.LAB 499114
11 EX-101.PRE zbio-20240930_pre.xml EX-101.PRE 389622
87 EXTRACTED XBRL INSTANCE DOCUMENT zbio-20240930x10q_htm.xml XML 1190744
Mailing Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451
Business Address 1000 WINTER ST, SUITE 1200 WALTHAM MA 02451 857-271-2954
Zenas BioPharma, Inc. (Filer) CIK: 0001953926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42270 | Film No.: 241443356
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)